Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
3.320
+0.070 (2.15%)
At close: May 22, 2025, 4:00 PM
3.340
+0.020 (0.60%)
After-hours: May 22, 2025, 7:30 PM EDT
Sonoma Pharmaceuticals Employees
Sonoma Pharmaceuticals had 10 employees as of March 31, 2024. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
$1,397,300
Profits / Employee
-$374,800
Market Cap
5.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
SNOA News
- 4 weeks ago - Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) - Accesswire
- 3 months ago - Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando - Accesswire
- 3 months ago - Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results - Accesswire
- 6 months ago - Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices - Accesswire
- 6 months ago - Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - Accesswire
- 6 months ago - Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - Accesswire
- 7 months ago - Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - Accesswire